# Measure of Microglial Activation in the Brain of Parkinson Disease Patients With PET

> **NCT02319382** · NA · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 46 (estimated)

## Conditions studied

- Parkinson's Disease With LRRK2 Mutation
- Healthy Controls
- Parkinson's Disease Without LRRK2 Mutation

## Interventions

- **RADIATION:** PET with the tracer 18F-DPA-714
- **RADIATION:** PET with the tracer 11C-PE2I
- **OTHER:** MRI

## Key facts

- **NCT ID:** NCT02319382
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-06
- **Primary completion:** 2016-11
- **Final completion:** 2016-12
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2015-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02319382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02319382, "Measure of Microglial Activation in the Brain of Parkinson Disease Patients With PET". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02319382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*